Phase II study of Lenalidomide in MCL
Results of the MCL-002 (SPRINT) Study (Abstract 626).
At ASH 2014, Dr. Marek Trneny discussed his abstract titled Phase II Randomized, Multicenter Study of Lenalidomide Vs Best Investigator’s Choice ...
Author: feeds
Added: 04/15/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts